Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 3 de 3
Filter
Add filters








Language
Year range
1.
Clinical and Experimental Reproductive Medicine ; : 95-98, 2019.
Article in English | WPRIM | ID: wpr-763352

ABSTRACT

Obstructive azoospermia caused by acute epididymitis is usually permanent, and microsurgical vasoepididymostomy is the only reconstructive treatment option. There have been no reports of delayed recovery of sperm count after over 1 year in a patient with obstructive azoospermia related to history of acute epididymitis. We present a young male patient who had azoospermia and a history of acute epididymitis who experienced delayed recovery, with complete restoration of sperm production and the ability to conceive naturally.


Subject(s)
Humans , Male , Azoospermia , Epididymitis , Infertility , Sperm Count , Spermatozoa
2.
Clinical and Experimental Reproductive Medicine ; : 173-177, 2019.
Article in English | WPRIM | ID: wpr-785642

ABSTRACT

OBJECTIVE: We investigated the clinical characteristics of men with testosterone replacement therapy (TRT)-induced hypogonadism and its effect on assisted reproductive technology (ART) in infertile couples.METHODS: This study examined the records of 20 consecutive male patients diagnosed with azoospermia or severe oligozoospermia (<5×10⁶/mL) who visited a single infertility center from January 2008 to July 2018. All patients were treated at a primary clinic for erectile dysfunction or androgen deficiency symptoms combined with low serum testosterone. All men received a phosphodiesterase 5 inhibitor and TRT with testosterone undecanoate (Nebido®) or testosterone enanthate (Jenasteron®). Patients older than 50 years or with a chronic medical disease such as diabetes were excluded.RESULTS: The mean age of patients was 37 years and the mean duration of infertility was 16.3±11.6 months. At the initial presentation, eight patients had azoospermia, nine had cryptozoospermia, and three had severe oligozoospermia. Serum follicle-stimulating hormone levels were below 1.0 mIU/mL in most patients. Three ongoing ART programs with female factor infertility were cancelled due to male spermatogenic dysfunction; two of these men had normal semen parameters in the previous cycle. After withholding TRT, serum hormone levels and sperm concentrations returned to normal range after a median duration of 8 months.CONCLUSION: TRT with high-dose testosterone can cause spermatogenic dysfunction due to suppression of the hypothalamic-pituitary-testicular axis, with adverse effects on infertility treatment programs. TRT is therefore contraindicated for infertile couples attempting to conceive, and the patient's desire for fertility must be considered before initiation of TRT in a hypogonadal man.


Subject(s)
Female , Humans , Male , Azoospermia , Cyclic Nucleotide Phosphodiesterases, Type 5 , Erectile Dysfunction , Family Characteristics , Fertility , Follicle Stimulating Hormone , Hypogonadism , Infertility , Infertility, Male , Oligospermia , Reference Values , Reproductive Techniques, Assisted , Semen , Spermatozoa , Testosterone
3.
Clinical and Experimental Reproductive Medicine ; : 202-205, 2019.
Article in English | WPRIM | ID: wpr-785638

ABSTRACT

Hyperprolactinemia due to a pituitary adenoma is a rare cause of erectile dysfunction (ED). The prevalence of clinically apparent prolactinomas is reported to be from 6–10 to 50 per 100,000. A few reports have been published of prolactinoma presenting with ED. Here, we report a rare case of a young man who presented with ED as a chief complaint and who was diagnosed with a huge prolactinoma, and we discuss a related fertility issue.


Subject(s)
Male , Erectile Dysfunction , Fertility , Hyperprolactinemia , Pituitary Neoplasms , Prevalence , Prolactinoma
SELECTION OF CITATIONS
SEARCH DETAIL